Nanopharm Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 74

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Nanopharm General Information

Description

Provider of tailored analytical and drug development services focuses on orally inhaled and nasal drug products. The company offers materials characterization, formulation development and inhaled biopharmaceutics together with in silico modelling aids successful product development by understanding how material properties and processing conditions influence product functionality, thereby enbaling clients a seamless translation of pre-clinical development through to clinical manufacturing.

Contact Information

Website
www.nanopharm.co.uk
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Cavendish House
  • Newport NP10 8FY
  • England, United Kingdom
+44 01633
Primary Industry
Other Healthcare Services
Other Industries
Consulting Services (B2B)
Drug Discovery
Parent Company
AptarGroup
Corporate Office
  • Cavendish House
  • Newport NP10 8FY
  • England, United Kingdom
+44 01633

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanopharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nanopharm‘s full profile, request access.

Request a free trial

Nanopharm Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of tailored analytical and drug development services focuses on orally inhaled and nasal drug products. The com
Other Healthcare Services
Newport, United Kingdom
74 As of 2023

Glasgow, United Kingdom
 

Elverum, Norway
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanopharm Competitors (3)

One of Nanopharm’s 3 competitors is BDD, a Venture Capital-Backed company based in Glasgow, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BDD Venture Capital-Backed Glasgow, United Kingdom
Curida Private Equity-Backed Elverum, Norway
Quotient Sciences Private Equity-Backed Nottingham, United Kingdom
You’re viewing 3 of 3 competitors. Get the full list »

Nanopharm Patents

  • 33

    Total Documents Applications and Grants

  • Total Patents Families

  • 21

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

Nanopharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202414899-D0 Dry powder formulations Pending 10-Oct-2024
GB-202414900-D0 Liquid formulations Pending 10-Oct-2024
GB-202414896-D0 Dry powder formulations Pending 10-Oct-2024
GB-202200809-D0 Inhaleable formulations Pending 21-Jan-2022
GB-2614901-A Inhalable formulations Pending 21-Jan-2022 A61K45/06
To view Nanopharm’s complete patent history, request access »

Nanopharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanopharm FAQs

  • When was Nanopharm founded?

    Nanopharm was founded in 2002.

  • Where is Nanopharm headquartered?

    Nanopharm is headquartered in Newport, United Kingdom.

  • What is the size of Nanopharm?

    Nanopharm has 74 total employees.

  • What industry is Nanopharm in?

    Nanopharm’s primary industry is Other Healthcare Services.

  • Is Nanopharm a private or public company?

    Nanopharm is a Private company.

  • What is the current valuation of Nanopharm?

    The current valuation of Nanopharm is .

  • What is Nanopharm’s current revenue?

    The current revenue for Nanopharm is .

  • Who are Nanopharm’s competitors?

    BDD, Curida, and Quotient Sciences are competitors of Nanopharm.

  • When was Nanopharm acquired?

    Nanopharm was acquired on 05-Jun-2019.

  • Who acquired Nanopharm?

    Nanopharm was acquired by AptarGroup.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »